3rd GLP-1 Based Therapeutics Summit 2026

 

 

The 3rd GLP-1 Based Therapeutics Summit is the essential industry forum dedicated to solving the critical challenges of GLP-1 combinations, mastering tolerability, drug delivery, and seizing the multi-billion dollar opportunity in non-obesity indications.

This year, we’re diving deep into the game-changing potential of multi-agonist combinations, next-generation tolerability, and strategic commercial planning.

Hear from the titans of the pharmaceutical industry, including Eli Lilly, AstraZeneca, Merck, and Takeda, as well as innovative biotechs and financial institutions who will share their groundbreaking research and strategies for developing best-in-class treatments that transform patient lives.

More Info

---

---